During latest LuCE Report launching event, Stefania Vallone, LuCE’s President encouraged the attendees to give a step forward, and try working together to get improvement in access to innovative therapies and healthcare services, ensuring sustainability of different health-care systems and tackle the burden of this disease, offering more equal conditions to thousands of individuals across Europe affected by lung cancer. […]
Stefania, Vallone, LuCE President, was key note speaker @IASLC Lung Cancer Immunotherapy Meeting, held between March 22-25, 2018 in Barcelona. She was presenting patient perspective on lung cancer treatment progress, by providing useful insight information on patient helth literacy on immunotherapy. You can find the presentation here: https://bit.ly/2I1IExi
LuCE’s vice-president Ewelina Szmytke was among the interviewees on patients advocates attendance importance at IASLC World Conference on #LungCancer. You can apply for a patient advocate travel award following the interview link. In its efforts to increase links to patient advocates and advocacy organizations around the world, IASLC will offer travel awards to a limited number of patient advocates to attend […]
This third edition of the Masterclass brought together senior representatives of European and international cancer patient networks as well as a small number of future leaders. The main topics covered were: • Lobbying for change • Building effective and sustainable EU cancer patient networks (leadership, effectiveness, challenges of working with industry, Boards) • Achieving sustainable access to cancer therapies • […]
